Passage Bio
PASG
PASG
44 hedge funds and large institutions have $27.1M invested in Passage Bio in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
15% less capital invested
Capital invested by funds: $32M → $27.1M (-$4.93M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
44
Holding in Top 10
2
Calls
$6K
Puts
–
Top Buyers
| 1 | +$2.36M | |
| 2 | +$187K | |
| 3 | +$171K | |
| 4 |
SC
Shay Capital
New York
|
+$64.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.9K |
Top Sellers
| 1 | -$3.2M | |
| 2 | -$411K | |
| 3 | -$375K | |
| 4 |
O
OrbiMed
New York
|
-$211K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$210K |